Unity Biotechnology

YTD

ALL

Why Robinhood?

You can watch UNBX and buy or sell other stocks, ETFs, and their options commission-free!

About UNBX

Unity Biotechnology, Inc. operates as a biotechnology company. The firm is developing a portfolio of programs like biological mechanisms implicated in diseases of aging, and also senolytic programs in ophthalmologic and neurologic disorders.

CEO

Craig R. Jalbert

CEOCraig R. Jalbert

Employees

Employees16

Headquarters

South San Francisco, California

HeadquartersSouth San Francisco, California

Founded

2009

Founded2009

Employees

Employees16

UNBX Key Statistics

Market cap

965.60K

Market cap965.60K

Price-Earnings ratio

-0.03

Price-Earnings ratio-0.03

Dividend yield

—

Dividend yield—

Average volume

54.60K

Average volume54.60K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$3.10

52 Week high$3.10

52 Week low

$0.0487

52 Week low$0.0487

People also own

Based on the portfolios of people who own UNBX. This list is generated using Robinhood data, and it’s not a recommendation.

Catalyst Pharmaceuticals